| 发明名称 |
KETAMINE TRANSDERMAL DELIVERY SYSTEM |
| 摘要 |
TThe present invention is directed to a transdermal delivery device comprising ketamine and formulations thereof. The present invention is also directed to a transdermal delivery device comprising ketamine for the treatment of major depressive disorder (MDD) and/or pain. The present invention is further directed to a transdermal delivery device comprising ketamine and abuse deterrent agents. |
| 申请公布号 |
WO2017003935(A1) |
申请公布日期 |
2017.01.05 |
| 申请号 |
WO2016US39601 |
申请日期 |
2016.06.27 |
| 申请人 |
SHENOX PHARMACEUTICALS, LLC |
发明人 |
TANG, Huadong;TAN, Hock S.;MAYERSOHN, Michael |
| 分类号 |
A61K31/135;A61K9/70;A61P25/24 |
主分类号 |
A61K31/135 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
